IL6 and Alzheimer disease: However, intermediate levels of IL-6 had no significant effect on the final clinical endpoint [OR = 1.06, 95% CI (0.8, 1.32)].<h4>Conclusion</h4>The data from cross-sectional studies suggest a higher level of inflammatory cytokines in AD and MCI as compared to controls.